Novartis AG (NOT)
XDUS
Real-time Data
06:00 AM
Day's Range
133.7052 wk Range
102.70Overview - NOT - Novartis AG
Key Statistics
Valuation
Enterprise Value
23.94B
P/E (Trailing)
‪18.74‬
PEG Ratio
‪-1.07‬
Price / Book
‪6.13‬
EV / EBITDA
‪1.03‬
Profitability
Gross Margin
‪75.18%‬
Profit Margin
‪75.82%‬
Operating Margin
‪30.87%‬
Return on Assets
‪12.60%‬
Return on Equity
‪30.04%‬
Ownership
Shares Outstanding
1.90B
Price stats
50-Day Avg
‪134.03‬
200-Day Avg
‪127.80‬
Dividends
Frequency
Annual
Peers - NOT - Novartis AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XDUS.
- NOTXDUSNovartis AG Registered Shares+20.53%52-week change18.93P/E (Trailing)‪75.82%‬Profit Margin
- LLYXDUSEli Lilly and Company+43.08%52-week change46.79P/E (Trailing)‪83.04%‬Profit Margin
- BAYAXDUSBayer AG Sponsored ADR+42.50%52-week change-13.04P/E (Trailing)‪58.75%‬Profit Margin
- 6MKXDUSMerck & Co., Inc.+41.66%52-week change17.34P/E (Trailing)‪74.80%‬Profit Margin
- IDPXDUSBiogen Inc.+35.99%52-week change21.13P/E (Trailing)‪75.69%‬Profit Margin
- JNJXDUSJohnson & Johnson+33.33%52-week change20.82P/E (Trailing)‪67.87%‬Profit Margin
- JNJ0XDUSJohnson & Johnson CDR+32.38%52-week change19.41P/E (Trailing)‪67.87%‬Profit Margin
Profile Summary - NOT - Novartis AG
About
Novartis AG Registered Shares is the common equity of Novartis AG, a global pharmaceutical company headquartered in Basel, Switzerland. The shares represent ownership in a business focused on innovative medicines across major therapeutic areas, including oncology, immunology, cardiovascular, renal and metabolic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
